Subscribe
3 July 2025NewsEuropeTom Phillips

‘We created law’: G1/24 and the creation of the ‘diamond standard’

The architect of an historic change in the way patent claims are interpreted explains what it means for AI drafting, and why more harmonisation may follow, reports Tom Phillips.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Broad Institute wins appeal to restore CRISPR patent in Europe
26 June 2025   Biotech institute successfully challenges EPO decision revoking key CRISPR patent over priority rights | Appeal follows major changes to European law | Case returns to lower court for novelty and inventive step evaluation.
Europe
UPC rejects Alexion’s rehearing bid in spat with Amgen and Samsung
20 June 2025   Court sets strict rules on rehearing's, saying "only fundamental procedural defects can be the basis for a rehearing” | Follows UK blow to Alexion, allowing biosimilars onto market.


Editor's picks

IP agencies vital to pharma and biotech grind to a halt
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025

Editor's picks

Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Killing the golden goose of US drug innovation (Part II): Drug pricing myths
12 September 2025
Americas
Killing the golden goose of US drug innovation (Part I): Follow the money
10 September 2025
Americas
Smart ringleader: Could Ōura’s market dominance be under threat?
5 September 2025
Americas
Why Masimo’s ‘rare’ move pushes Apple case into uncharted territory
3 September 2025
Europe
Sandoz blocked by UK court from seeking Xarelto profits
2 September 2025

More features

IP agencies vital to pharma and biotech grind to a halt
USPTO trims workforce amid govt shutdown crisis
How impactful is the new USPTO director’s S101 decision?
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
Philips wins unprecedented trade secret sanctions against Chinese defendants
Womble Bond Dickinson partners jump to rival firm
EPO ruling clarifies appeal rights, blocking third-party intervention
Biotech sues AstraZeneca and Cellectis over mRNA patents